摘要
基于石墨烯纳米材料混合磁性纳米粒的利用在现代生物医学方面提供了关键的优势。在这篇小综述中,我们关注磁性石墨烯杂化衍生物在生物医学应用方面的最新进展。我们初步分析了几种采用磁性纳米粒制备石墨烯基复合物的方法,特别是两种成分之间的联系。接着,我们关注磁性石墨烯混合物在如何提高在磁共振成像、控制药物释放、磁性光热治疗和细胞分离方面的生物医学应用。最后,我们强调使用这种磁性混合物作为复合功能性材料将领导下一代的治疗发展。
关键词: 石墨烯,石墨烯衍生物,磁性纳米粒,生物医学应用,磁共振成像,药物释放,光热治疗,细胞分离。
Current Medicinal Chemistry
Title:Recent Advances of Graphene-based Hybrids with Magnetic Nanoparticles for Biomedical Applications
Volume: 24 Issue: 5
关键词: 石墨烯,石墨烯衍生物,磁性纳米粒,生物医学应用,磁共振成像,药物释放,光热治疗,细胞分离。
摘要: The utilization of graphene-based nanomaterials combined with magnetic nanoparticles offers key benefits in the modern biomedicine. In this minireview, we focus on the most recent advances in hybrids of magnetic graphene derivatives for biomedical applications. We initially analyze the several methodologies employed for the preparation of graphene-based composites with magnetic nanoparticles, more specifically the kind of linkage between the two components. In the last section, we focus on the biomedical applications where these magnetic-graphene hybrids are essential and pay special attention on how the addition of graphene improves the resulting devices in magnetic resonance imaging, controlled drug delivery, magnetic photothermal therapy and cellular separation and isolation. Finally, we highlight the use of these magnetic hybrids as multifunctional material that will lead to a next generation of theranostics.
Export Options
About this article
Cite this article as:
Recent Advances of Graphene-based Hybrids with Magnetic Nanoparticles for Biomedical Applications, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666161216144218
DOI https://dx.doi.org/10.2174/0929867323666161216144218 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model
Anti-Cancer Agents in Medicinal Chemistry Anticancer Properties of Asian Water Monitor Lizard (Varanus salvator), Python (Malayopython reticulatus) and Tortoise (Cuora kamaroma amboinensis)
Anti-Cancer Agents in Medicinal Chemistry A Better Platinum-Based Anticancer Drug Yet to Come?
Anti-Cancer Agents in Medicinal Chemistry Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine DNA and RNA Code-reading Molecules as Potential Gene Silencers in Neurobiology- What are They and what are They Good for?
Current Medicinal Chemistry - Central Nervous System Agents Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Understanding Autophagy in Cell Death Control
Current Pharmaceutical Design Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Bioactive Peptides from Marine Organisms: A Short Overview
Protein & Peptide Letters Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Current Molecular Pharmacology The Synthesis of Nano-Doxorubicin and its Anticancer Effect
Anti-Cancer Agents in Medicinal Chemistry Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection
Infectious Disorders - Drug Targets Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Pathogenic Genes Selection Model of Genetic Disease based on Network Motifs Slicing Feedback
Current Proteomics Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety